Study for acquiring extended data on the clinical applicability of “AllergoEye” (an AI-based software, CE certified) for the automatic redness determination of the sclera of the eye based on photographs. “AllergoEye” as an aid in evaluating results of the conjunctival provocation test (KPT)

Study for acquiring extended data on the clinical applicability of “AllergoEye” (an AI-based software, CE certified) for the automatic redness determination of the sclera of the eye based on photographs. “AllergoEye” as an aid in evaluating results of the conjunctival provocation test (KPT) - AllergoEye

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00033338

Enrollment

Registered

2024-01-04

Start date

2021-11-30

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

J30.1

Interventions

Group 1: Patients with allergic rhinoconjunctivitis

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: -Presence of a signed and dated informed consent form from the patient -Presence of a suspected diagnosis of allergic rhinoconjunctivitis -Patient is able to fill out the questionnaires -Consent to subcutaneous or sublingual immunotherapy

Exclusion criteria

Exclusion criteria: -Current participation in other clinical trials -Acute or chronic eye diseases especially all forms of conjunctivitis or glaucoma -Severe acute and/or chronic organic or mental illness, including the presence of epilepsy -Contraindications to SLIT/SCIT -Inadequate method of contraception (double contraception is necessary) -Pregnancy -Chronic non-allergic rhinitis -Intolerance to antihistamines and/or cortisone preparations -Presence of type III and/or type IV allergy -Current or expired complementary medical therapy as well as planned complementary medical therapy during the study period

Design outcomes

Primary

Measure	Time frame
Proof of the usability and effectiveness of the “AllergoEye” system in diagnostics and during the three-year therapy in 50 patients with allergic rhinoconjunctivitis	—

Secondary

Measure	Time frame
a. Confirmation that when comparing the results of the “AllergoEye” with the subjective assessment of the medical staff, “AllergoEye” demonstrates a better qualitative and quantitative performance. b. Proof that the accuracy of the Summation Symptom Scores is qualitatively increased when using the “AllergoEye” redness measurement instead of the subjective assessment by medical staff. c. Proof that the results obtained by “AllergoEye” correlate exactly with the Summation Symptom Scores and that “AllergoEye” is therefore able to replace the complex, subjective methodology of the Summation Symptom Scores.	—

Measure

Time frame

a. Confirmation that when comparing the results of the “AllergoEye” with the subjective assessment of the medical staff, “AllergoEye” demonstrates a better qualitative and quantitative performance. b. Proof that the accuracy of the Summation Symptom Scores is qualitatively increased when using the “AllergoEye” redness measurement instead of the subjective assessment by medical staff. c. Proof that the results obtained by “AllergoEye” correlate exactly with the Summation Symptom Scores and that “AllergoEye” is therefore able to replace the complex, subjective methodology of the Summation Symptom Scores.

—

Countries

Germany

Contacts

Public ContactYury Yarin

Praxis für HNO und Allergologie Dr. Yury Yarin

dr.yarin@googlemail.com+49 3514278055

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026